Clinical Trial Update: Resistant Maltodextrin for Gut Microbiome in Parkinson's Disease: Safety and Tolerability Study [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating resistant maltodextrin for safety and tolerability in Parkinson's disease related to gut microbiome modulation; currently acti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Resistant Maltodextrin (resistant maltodextrin)

Snippet

Sponsor: Northwestern University | Conditions: Parkinson Disease, Intestinal Bacteria Flora Disturbance | Phase 2 | Status: ACTIVE_NOT_RECRUITING